ConductScience.org, home

Paper772425

Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone.

Woods JW and 5 others. N Engl J Med, 1976. Cited by 110 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone. Papers, record 772425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/772425

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone.
PubMed
Journal
N Engl J Med
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
110
iCite
Relative citation ratio, by iCite
5.06
iCite
Revised in PubMed
2022-12-07
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Woods JWJ W
2Pittman AWA W
3Pulliam CCC C
4Werk EE JrE E
5Waider WW
6Allen CAC A

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ChlorthalidoneMajor topic
HypertensionMajor topic
PropranololMajor topic
ReninMajor topic
Adult
Age Factors
Black People
Blood Pressure
Clinical Trials as Topic
Female
Humans
Male
Middle Aged
Posture
Prospective Studies
Sex Factors
Sodium
White People

Source PubMed

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.

PMIDTitleJournalYearIn PapersSource
32,697,680Metabolomics, Lipid Pathways, and Blood Pressure Change.Arterioscler Thromb Vasc Biol2020https://conductscience.org/library/papers/32697680PubMed
28,057,892Hypothalamic and inflammatory basis of hypertension.Clin Sci (Lond)2017https://conductscience.org/library/papers/28057892PubMed
27,587,277Influence of Age and Race on 24-Hour Ambulatory Blood Pressure Responses to Valsartan, Hydrochlorothiazide, and Their Combination: Implications for Clinical Practice.J Clin Hypertens (Greenwich)2017https://conductscience.org/library/papers/27587277PubMed
25,693,856Environmental origins of hypertension: phylogeny, ontogeny and epigenetics.Hypertens Res2015https://conductscience.org/library/papers/25693856PubMed
21,814,209
The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain.
Hypertens Res2011https://conductscience.org/library/papers/21814209PubMed
20,725,057Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension.Am J Hypertens2010https://conductscience.org/library/papers/20725057PubMed
18,749,429Hypertension symposium: newer topics on normal and abnormal blood pressure regulatory mechanisms.West J Med1983https://conductscience.org/library/papers/18749429PubMed
7,032,946The response to the angiotensin antagonist saralasin in predicting therapeutic outcome in hypertension treated with frusemide.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7032946PubMed
7,030,750Correlation between propranolol in plasma and urine, renin-aldosterone system and blood pressure in essential hypertension.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7030750PubMed
6,994,760A study of the effects of atenolol and propranolol on renal function in patients with essential hypertension.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6994760PubMed
6,992,462Antihypertensive pharmacology.West J Med1980https://conductscience.org/library/papers/6992462PubMed
3,891,306Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.Drugs1985https://conductscience.org/library/papers/3891306PubMed
3,889,356Propranolol versus labetalol: interesting differences in efficacy.J Natl Med Assoc1985https://conductscience.org/library/papers/3889356PubMed
1,980,202The efficacy of beta-adrenoceptor and calcium-entry blockers in hypertensive blacks.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/1980202PubMed
902,672Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.Eur J Clin Pharmacol1977https://conductscience.org/library/papers/902672PubMed
359,018Acebutolol in hypertension--double-blind trial against placebo.Br J Clin Pharmacol1978https://conductscience.org/library/papers/359018PubMed
23,284Antihypertensive drugs: clinical pharmacology and therapeutic use.Drugs1977https://conductscience.org/library/papers/23284PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5,972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/772425

GET https://conductscience.org/api/papers/v1/772425/authors